WuXi AppTec is dedicated to advancing global pharmaceutical and healthcare innovation through comprehensive drug research, development, and manufacturing services. With facilities across Asia, Europe, and North America, the company employs its unique "CRDMO" model to reduce research and development barriers, improve client efficiency, and enable the delivery of innovative treatments to patients.
Its services primarily include biology, small molecule drugs, R&D, testing, clinical trials, as well as oligonucleotides and peptides.
Copyright © China Daily. All rights reserved.